MetaCap

Bicara Therapeutics Inc. Company Profile

NASDAQ: BCAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.44-0.68 (-7.46%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Bicara Therapeutics at a glance

Bicara Therapeutics Inc. (NASDAQ: BCAX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Boston, MA. Bicara Therapeutics is led by Dr. Claire Mazumdar Clemon M.B.A., Ph.D. and employs about 103 people. The company's shares have traded publicly since 2024.

At a market capitalization of $560.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002023658, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Bicara Therapeutics do?

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Bicara Therapeutics Inc.
Ticker
NASDAQ: BCAX
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Claire Mazumdar Clemon M.B.A., Ph.D.
Employees
103
Headquarters
116 Huntington Avenue, Boston, MA, United States
Phone
617 468 4219
Website
bicara.com
IPO year
2024
Market cap
$560.31M
SEC CIK
0002023658
Latest annual report
10-K · Mar 30, 2026

Companies similar to Bicara Therapeutics

BCAX peer companies
CompanyPrice% ChgMarket capCompare
GERNGeron Corporation0.8707-4.63%$560.94Mvs BCAX
ANLAdlai Nortye Group Ltd. ADR8.55-5.63%$550.60Mvs BCAX
ACRSAclaris Therapeutics Inc.3.44-1.71%$545.63Mvs BCAX
AVBPArriVent BioPharma Inc.10.52-6.57%$544.13Mvs BCAX
CBIOCrescent Biopharma Inc.13.00+0.70%$543.21Mvs BCAX
DSGNDesign Therapeutics Inc.9.02-3.22%$577.61Mvs BCAX
CLYMClimb Bio Inc.9.19-0.97%$539.80Mvs BCAX
IMMXImmix Biopharma Inc.6.96-1.14%$583.33Mvs BCAX

Related